“Technological Advancements and Expanding Clinical Indications”
- A prominent trend in the SNS market is the development of miniaturized and rechargeable devices that offer extended battery life, wireless programmability, and greater comfort for patients.
- MRI-compatible SNS systems are becoming standard, addressing safety concerns for patients needing frequent imaging and broadening adoption in neurogenic disorder treatment.
- Companies are introducing remote programming capabilities that allow physicians to adjust stimulation settings without in-person clinic visits—supporting the rise of telehealth in neuromodulation.
- Clinical trials and off-label research are expanding the use of SNS beyond incontinence into areas like interstitial cystitis, erectile dysfunction, and chronic pelvic pain syndromes.
- The market is also witnessing a shift toward day-care and ambulatory-based SNS implantation, reducing hospitalization costs and improving access in outpatient settings.
